March 22, 2012New England Journal of Medicine139 citationsOpen Access
View Full PaperEculizumab in a Patient with Dense-Deposit Disease
Key Points
Key points are not available for this paper at this time.
Abstract
This letter indicates that in a patient with long-standing dense-deposit disease, a variant of membranoproliferative glomerulonephritis, eculizumab can be useful in the resolution of the nephrotic syndrome.